Chronic Kidney Disease Trial, Recruiting NCT07105670 Sponsor: Indiana University Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT07105670
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 40 and 70 years old
  • Men, or women who have gone through menopause
  • People who have been diagnosed with Stage 3 chronic kidney disease, meaning their kidneys are working at a reduced level (confirmed by a specific kidney function test result between 30–59 ml/min/1.73m²)
  • People whose kidney function test result is 45 or above must also have a high level of a protein called albumin in their urine (above 300mg/g creatinine on a urine test)
  • People who are willing to follow a controlled, set diet for the whole duration of the study
  • People who are willing to collect stool samples at home during the study

Who may not be able to join:

  • People whose blood sugar control test (HbA1c) showed a result above 7% in the last six months
  • People who have been treated with metformin or insulin in the last three months
  • People whose blood pressure has been recorded above 150/100 mmHg on at least two occasions in the past month
  • People who have had a change in their heart or blood pressure medications in the last 30 days
  • People with a history of significant bowel or digestive conditions, such as inflammatory bowel disease, uncontrolled irritable bowel syndrome, ongoing C. difficile infection, coeliac disease, diverticulitis, or stomach or duodenal ulcers
  • People with a known HIV diagnosis
  • People who have been hospitalised in the last two months
  • People who have lost 5% or more of their body weight without trying over the past three months
  • People who have had cancer or received cancer treatment in the past year (except for a type of minor skin cancer called basal cell carcinoma)
  • People who have previously had weight-loss (bariatric) surgery, such as gastric bypass, sleeve gastrectomy, or gastric band
  • People who have used immune-suppressing medications in the past six months, or who have taken a steroid called prednisone at a dose above 10mg per day for more than one week in the past three months (or an equivalent dose of a similar steroid)
  • People who have taken antibiotics in the past three months (even one course), or two or more courses of antibiotics in the past six months
  • People with a known food allergy that would make it difficult to follow the study's required diets
  • People who have had high potassium levels in their blood (above 5.5 mmol/L) on at least two separate occasions
  • People with other medical conditions or concerns that the trial investigators consider relevant (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 765-494-5406

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
30 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Serum trimethylamine N-oxide

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov